Scandinavian ChemoTech: Comment on directed issue and updated valuation
28 juli, 08:15
28 juli, 08:15
Redeye provides a short comment on the recently announced directed issue from Scandinavian ChemoTech. The company is raising cSEK5m at a premium to both the current share price and the 10-day VWAP. We are encouraged by the news, having previously modelled a small rights issue at a discount, and therefore raise our valuation slightly due to the lower-than-expected dilution.
28 juli, 08:15
Redeye provides a short comment on the recently announced directed issue from Scandinavian ChemoTech. The company is raising cSEK5m at a premium to both the current share price and the 10-day VWAP. We are encouraged by the news, having previously modelled a small rights issue at a discount, and therefore raise our valuation slightly due to the lower-than-expected dilution.
Handelskrig
Analys
Handelskrig
Analys
1 DAG %
Senast
Handelskrig
1 augusti, 15:51
Professorn: "Svårt att tänka sig en guldålder"
Kempower
1 augusti, 12:28
Laddat för tillväxt i Kempower
Novo Nordisk
1 augusti, 10:47
1000 miljarder utraderade i Novo Nordisk
OMX Stockholm 30
1 DAG %
Senast
2 533,59